Poor Astra Zeneca
Moderna and Pfizer are expected to make $18 and $15 billion in revenue this year respectively, thanks to their COVID-19 vaccines. Guess how much Astra-Zeneca, the British company, will make? Zero profit. That’s right, AZ sells at cost price. And yet, see the amount of flak and negative publicity they draw in the West? Sarah Boseley looked into the reasons . In America, the reasons are not political. Rather, it’s based on their (mis)handling of an early adverse reaction during clinical trial way back in September. In the UK, the trail was stopped and restarted within days. The US regulatory body though felt it had not been told of the issue early enough. The situation was also complicated, says Stephen Evans, a professor of pharmacoepidemiology in London by the intent of the trial: “I think that some of the difficulties were that the trials were being set up by Oxford to answer public health questions, whereas very clearly Pfizer/BioNTech and Moderna’s trials in the US were...